{{Rsnum
|rsid=2296135
|Gene=IL15RA
|Chromosome=10
|position=5994694
|Orientation=plus
|GMAF=0.4605
|Gene_s=IL15RA
|Assembly=GRCh37.p10
|GenomeBuild=37.5
|dbSNPBuild=138
|geno1=(A;A)
|geno2=(A;C)
|geno3=(C;C)
}}
{{ population diversity
| geno1=(A;A)
| geno2=(A;C)
| geno3=(C;C)
| CEU | 23.0 | 56.6 | 20.4
| HCB | 29.2 | 55.5 | 15.3
| JPT | 31.0 | 57.5 | 11.5
| YRI | 2.7 | 32.0 | 65.3
| ASW | 8.8 | 40.4 | 50.9
| CHB | 29.2 | 55.5 | 15.3
| CHD | 38.5 | 51.4 | 10.1
| GIH | 20.8 | 48.5 | 30.7
| LWK | 3.6 | 37.3 | 59.1
| MEX | 37.9 | 41.4 | 20.7
| MKK | 8.3 | 43.6 | 48.1
| TSI | 20.6 | 49.0 | 30.4
| HapMapRevision=28
}}{{PMID Auto
|PMID=23996684
|Title=Cytokine and cytokine receptor genes of the adaptive immune response are differentially associated with breast cancer risk in American women of African and European ancestry
}}

{{PMID Auto
|PMID=16449530
|Title=Cytokine polymorphisms in the Th1/Th2 pathway and susceptibility to non-Hodgkin lymphoma.
|OA=1
}}

{{PMID Auto
|PMID=17327408
|Title=Prognostic significance of host immune gene polymorphisms in follicular lymphoma survival.
|OA=1
}}

{{PMID Auto
|PMID=18514540
|Title=Interleukin-15 and interleukin-15R alpha SNPs and associations with muscle, bone, and predictors of the metabolic syndrome.
|OA=1
}}

{{PMID Auto
|PMID=18633131
|Title=Host immune gene polymorphisms in combination with clinical and demographic factors predict late survival in diffuse large B-cell lymphoma patients in the pre-rituximab era.
|OA=1
}}

{{PMID Auto
|PMID=19066394
|Title=Organochlorine exposure, immune gene variation, and risk of non-Hodgkin lymphoma.
|OA=1
}}

{{PMID Auto
|PMID=19356949
|Title=Cytokine SNPs: Comparison of allele frequencies by race and implications for future studies.
|OA=1
}}

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | Affy GenomeWide 6}}
{{on chip | FTDNA2}}
{{on chip | FTDNA}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}